Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

DuoResp® Spiromax® adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT).

van der Palen J, Cerveri I, Roche N, Singh D, Plaza V, Gonzalez C, Patino O, Scheepstra I, Safioti G, Backer V.

J Asthma. 2019 Jul 11:1-9. doi: 10.1080/02770903.2019.1634097. [Epub ahead of print]

PMID:
31293211
2.

The long-term effect of an exercise and diet intervention in asthma patients: a 1-year follow-up on a randomised controlled trial.

Bentzon AK, Loehde LW, Backer V, Toennesen L.

ERJ Open Res. 2019 Jun 24;5(2). pii: 00032-2019. doi: 10.1183/23120541.00032-2019. eCollection 2019 Apr.

3.
4.

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA and TERRANOVA Study Investigators.

N Engl J Med. 2019 May 20. doi: 10.1056/NEJMoa1905248. [Epub ahead of print]

PMID:
31112385
5.

A systematic review of surgical treatment for supraglottic exercise-induced laryngeal obstruction.

Siewers K, Backer V, Walsted ES.

Laryngoscope Investig Otolaryngol. 2019 Mar 6;4(2):227-233. doi: 10.1002/lio2.257. eCollection 2019 Apr. Review.

6.

Exposure to Vitamin D Fortification Policy in Prenatal Life and the Risk of Childhood Asthma: Results From the D-Tect Study.

Thorsteinsdottir F, Maslova E, Jacobsen R, Frederiksen P, Keller A, Backer V, Heitmann BL.

Nutrients. 2019 Apr 24;11(4). pii: E924. doi: 10.3390/nu11040924.

7.

Listening to music prior to bronchoscopy reduces anxiety - a randomised controlled trial.

Jeppesen E, Pedersen CM, Larsen KR, Walsted ES, Rehl A, Ehrenreich J, Schnoor S, Backer V.

Eur Clin Respir J. 2019 Mar 17;6(1):1583517. doi: 10.1080/20018525.2019.1583517. eCollection 2019.

8.

Association Between Chronic Obstructive Pulmonary Disease and Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Rasmussen SM, Brok J, Backer V, Thomsen SF, Meteran H.

COPD. 2018 Oct;15(5):526-535. doi: 10.1080/15412555.2018.1532495.

PMID:
30822245
9.
10.

High Prevalence of Laryngeal Obstruction during Exercise in Severe Asthma.

Hull JH, Walsted ES, Pavitt MJ, Menzies-Gow A, Backer V, Sandhu G.

Am J Respir Crit Care Med. 2019 Feb 15;199(4):538-542. doi: 10.1164/rccm.201809-1734LE. No abstract available.

PMID:
30570393
11.

Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.

von Bülow A, Backer V, Bodtger U, Søes-Petersen NU, Vest S, Steffensen I, Porsbjerg C.

Respir Med. 2018 Dec;145:41-47. doi: 10.1016/j.rmed.2018.10.020. Epub 2018 Oct 22.

PMID:
30509715
12.

Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study.

Zierau L, Cortes R, Thomsen SF, Jimenez-Solem E, Lindenberg S, Backer V.

ERJ Open Res. 2018 Nov 5;4(4). pii: 00138-2017. doi: 10.1183/23120541.00138-2017. eCollection 2018 Oct.

13.

Validation of ATS clinical practice guideline cut-points for FeNO in asthma.

Jeppegaard M, Veidal S, Sverrild A, Backer V, Porsbjerg C.

Respir Med. 2018 Nov;144:22-29. doi: 10.1016/j.rmed.2018.09.014. Epub 2018 Sep 22.

PMID:
30366580
14.

Self-reported intake of fruit and vegetables and risk of chronic obstructive pulmonary disease: A nation-wide twin study.

Meteran H, Thomsen SF, Miller MR, Hjelmborg J, Sigsgaard T, Backer V.

Respir Med. 2018 Nov;144:16-21. doi: 10.1016/j.rmed.2018.09.013. Epub 2018 Sep 20.

PMID:
30366579
15.

F eNO-based asthma management results in faster improvement of airway hyperresponsiveness.

Bernholm KF, Homøe AS, Meteran H, Jensen CB, Porsbjerg C, Backer V.

ERJ Open Res. 2018 Oct 3;4(4). pii: 00147-2017. doi: 10.1183/23120541.00147-2017. eCollection 2018 Oct.

16.

Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management.

Backer V, Ellery A, Borzova S, Lane S, Kleiberova M, Bengtsson P, Tomala T, Basset-Stheme D, Bennett C, Lindner D, Meiners A, Overend T.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618796987. doi: 10.1177/1753466618796987.

17.

Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study.

Bulathsinhala L, Eleangovan N, Heaney LG, Menzies-Gow A, Gibson PG, Peters M, Hew M, van Boven JFM, Lehtimäki L, van Ganse E, Belhassen M, Harvey ES, Perez de Llano L, Maitland-van der Zee AH, Papadopoulos NG, FitzGerald JM, Porsbjerg C, Canonica GW, Backer V, Rhee CK, Verhamme KMC, Buhl R, Cosio BG, Carter V, Price C, Le T, Stagno d'Alcontres M, Gopalan G, Tran TN, Price D.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):578-588.e2. doi: 10.1016/j.jaip.2018.08.016. Epub 2018 Sep 1.

PMID:
30179741
18.

Quantification and Analysis of Laryngeal Closure From Endoscopic Videos.

Lin J, Walsted ES, Backer V, Hull JH, Elson DS.

IEEE Trans Biomed Eng. 2019 Apr;66(4):1127-1136. doi: 10.1109/TBME.2018.2867636. Epub 2018 Aug 29.

19.

Beta2 -adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men.

Hostrup M, Reitelseder S, Jessen S, Kalsen A, Nyberg M, Egelund J, Kreiberg M, Kristensen CM, Thomassen M, Pilegaard H, Backer V, Jacobson GA, Holm L, Bangsbo J.

J Physiol. 2018 Sep;596(17):4121-4139. doi: 10.1113/JP275560. Epub 2018 Jul 30.

PMID:
29968301
20.

Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma.

Poulsen NN, Bjerregaard A, Khoo SK, Laing IA, Le Souëf P, Backer V, Rapley L, Cohen SE, Barrett L, Thompson P, Baltic S, Porsbjerg C.

Respir Med. 2018 Jul;140:50-56. doi: 10.1016/j.rmed.2018.05.016. Epub 2018 May 19.

PMID:
29957280
21.

Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.

Russell RJ, Chachi L, FitzGerald JM, Backer V, Olivenstein R, Titlestad IL, Ulrik CS, Harrison T, Singh D, Chaudhuri R, Leaker B, McGarvey L, Siddiqui S, Wang M, Braddock M, Nordenmark LH, Cohen D, Parikh H, Colice G, Brightling CE; MESOS study investigators.

Lancet Respir Med. 2018 Jul;6(7):499-510. doi: 10.1016/S2213-2600(18)30201-7. Epub 2018 May 21.

PMID:
29793857
22.

Feasibility of high-intensity training in asthma.

Toennesen LL, Soerensen ED, Hostrup M, Porsbjerg C, Bangsbo J, Backer V.

Eur Clin Respir J. 2018 May 11;5(1):1468714. doi: 10.1080/20018525.2018.1468714. eCollection 2018.

23.

Hypertrophic effect of inhaled beta2 -agonist with and without concurrent exercise training: A randomized controlled trial.

Jessen S, Onslev J, Lemminger A, Backer V, Bangsbo J, Hostrup M.

Scand J Med Sci Sports. 2018 Oct;28(10):2114-2122. doi: 10.1111/sms.13221. Epub 2018 Jun 7.

PMID:
29777633
24.

Pharmacologic Strategies for Exercise-Induced Bronchospasm with a Focus on Athletes.

Backer V, Mastronarde J.

Immunol Allergy Clin North Am. 2018 May;38(2):231-243. doi: 10.1016/j.iac.2018.01.011. Review.

PMID:
29631732
25.

Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults.

Porsbjerg C, Ulrik C, Skjold T, Backer V, Laerum B, Lehman S, Janson C, Sandstrøm T, Bjermer L, Dahlen B, Lundbäck B, Ludviksdottir D, Björnsdóttir U, Altraja A, Lehtimäki L, Kauppi P, Karjalainen J, Kankaanranta H.

Eur Clin Respir J. 2018 Mar 6;5(1):1440868. doi: 10.1080/20018525.2018.1440868. eCollection 2018. Review.

26.

Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax-a real life study.

Kiotseridis H, Arvidsson P, Backer V, Braendholt V, Tunsäter A.

NPJ Prim Care Respir Med. 2018 Feb 12;28(1):4. doi: 10.1038/s41533-018-0072-z.

27.

Allergic asthma is associated with increased risk of infections requiring antibiotics.

Woehlk C, von Bülow A, Kriegbaum M, Backer V, Porsbjerg C.

Ann Allergy Asthma Immunol. 2018 Feb;120(2):169-176.e1. doi: 10.1016/j.anai.2017.11.015.

PMID:
29413341
28.

The efficacy of a high protein/low glycemic index diet intervention in non-obese patients with asthma.

Geiker NRW, Toennesen LL, Astrup A, Backer V.

Eur J Clin Nutr. 2018 Apr;72(4):511-516. doi: 10.1038/s41430-018-0092-3. Epub 2018 Feb 6.

PMID:
29410479
29.

Lung function discordance in monozygotic twins and associated differences in blood DNA methylation.

Bolund ACS, Starnawska A, Miller MR, Schlünssen V, Backer V, Børglum AD, Christensen K, Tan Q, Christiansen L, Sigsgaard T.

Clin Epigenetics. 2017 Dec 21;9:132. doi: 10.1186/s13148-017-0427-2. eCollection 2017.

30.

Objective confirmation of asthma diagnosis improves medication adherence.

Backer V, Stensen L, Sverrild A, Wedge E, Porsbjerg C.

J Asthma. 2018 Nov;55(11):1262-1268. doi: 10.1080/02770903.2017.1410830. Epub 2017 Dec 26.

PMID:
29278942
31.

Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis.

Bäcker V, Cheung FY, Siveke JT, Fandrey J, Winning S.

PLoS One. 2017 Dec 20;12(12):e0190074. doi: 10.1371/journal.pone.0190074. eCollection 2017.

32.

The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms.

Meteran H, Miller MR, Thomsen SF, Christensen K, Sigsgaard T, Backer V.

ERJ Open Res. 2017 Dec 8;3(4). pii: 00110-2017. doi: 10.1183/23120541.00110-2017. eCollection 2017 Oct.

33.

Ergospirometry with concurrent fibre optic laryngoscopy: a randomised crossover study.

Mirza KK, Walsted ES, Backer V.

Eur Clin Respir J. 2017 Nov 20;4(1):1399033. doi: 10.1080/20018525.2017.1399033. eCollection 2017.

34.

Exhaled and nasal nitric oxide in chronic rhinosinusitis patients with nasal polyps in primary care.

Frendø M, Håkansson K, Schwer S, Ravn AT, Meteran H, Porsbjerg C, Backer V, von Buchwald C.

Rhinology. 2018 Mar 1;56(1):59-64. doi: 10.4193/Rhin17.111.

PMID:
29166423
35.

Effects of Exercise and Diet in Nonobese Asthma Patients-A Randomized Controlled Trial.

Toennesen LL, Meteran H, Hostrup M, Wium Geiker NR, Jensen CB, Porsbjerg C, Astrup A, Bangsbo J, Parker D, Backer V.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):803-811. doi: 10.1016/j.jaip.2017.09.028. Epub 2017 Nov 10.

PMID:
29133220
36.

Increased respiratory neural drive and work of breathing in exercise-induced laryngeal obstruction.

Walsted ES, Faisal A, Jolley CJ, Swanton LL, Pavitt MJ, Luo YM, Backer V, Polkey MI, Hull JH.

J Appl Physiol (1985). 2018 Feb 1;124(2):356-363. doi: 10.1152/japplphysiol.00691.2017. Epub 2017 Nov 2.

37.

Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.

Silkoff PE, Singh D, FitzGerald JM, Eich A, Ludwig-Sengpiel A, Chupp GC, Backer V, Porsbjerg C, Girodet PO, Dransfield MT, Baribaud F, Susulic VS, Loza MJ.

Biomark Insights. 2017 Sep 7;12:1177271917730306. doi: 10.1177/1177271917730306. eCollection 2017.

38.

The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.

Emminger W, Hernández MD, Cardona V, Smeenk F, Fogh BS, Calderon MA, de Blay F, Backer V.

Int Arch Allergy Immunol. 2017;174(1):35-44. doi: 10.1159/000478699. Epub 2017 Sep 27.

39.

Response to omalizumab in patients with severe allergic asthma: A real-life study.

Zierau L, Walsted ES, Thomsen SF, Backer V.

Respir Med. 2017 Oct;131:109-113. doi: 10.1016/j.rmed.2017.08.011. Epub 2017 Aug 12.

PMID:
28947015
40.

Heredity of supraglottic exercise-induced laryngeal obstruction.

Walsted ES, Hvedstrup J, Eiberg H, Backer V.

Eur Respir J. 2017 Aug 17;50(2). pii: 1700423. doi: 10.1183/13993003.00423-2017. Print 2017 Aug. No abstract available.

41.

Validity and reliability of grade scoring in the diagnosis of exercise-induced laryngeal obstruction.

Walsted ES, Hull JH, Hvedstrup J, Maat RC, Backer V.

ERJ Open Res. 2017 Jul 28;3(3). pii: 00070-2017. doi: 10.1183/23120541.00070-2017. eCollection 2017 Jul.

42.

Overweight in childhood and adolescence: Does it lead to airway hyperresponsiveness in adulthood?

Toennesen LL, Bjerregaard A, Porsbjerg C, Ulrik CS, Harmsen L, Backer V.

J Asthma. 2018 Feb;55(2):137-144. doi: 10.1080/02770903.2017.1318143. Epub 2017 Jul 31.

PMID:
28758814
43.

Environment Changes Genetic Effects on Respiratory Conditions and Allergic Phenotypes.

Song Y, Schwager MJ, Backer V, Guo J, Porsbjerg C, Khoo SK, Laing IA, Moses EK, LeSouëf P, Zhang GB.

Sci Rep. 2017 Jul 24;7(1):6342. doi: 10.1038/s41598-017-06791-y.

44.

Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study.

Silkoff PE, Flavin S, Gordon R, Loza MJ, Sterk PJ, Lutter R, Diamant Z, Turner RB, Lipworth BJ, Proud D, Singh D, Eich A, Backer V, Gern JE, Herzmann C, Halperin SA, Mensinga TT, Del Vecchio AM, Branigan P, San Mateo L, Baribaud F, Barnathan ES, Johnston SL.

J Allergy Clin Immunol. 2018 Apr;141(4):1220-1230. doi: 10.1016/j.jaci.2017.06.027. Epub 2017 Jul 20.

45.

Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD.

Karlsson SL, Backer V, Godtfredsen NS.

Chron Respir Dis. 2018 May;15(2):220-222. doi: 10.1177/1479972317721929. Epub 2017 Jul 18.

46.

Beta2-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men.

Onslev J, Jacobson G, Narkowicz C, Backer V, Kalsen A, Kreiberg M, Jessen S, Bangsbo J, Hostrup M.

Eur J Appl Physiol. 2017 Sep;117(9):1907-1915. doi: 10.1007/s00421-017-3679-9. Epub 2017 Jul 12.

PMID:
28702809
47.

Natural history of skin prick test reactivity: A 20-year prospective study of a random population sample of children and adolescents.

Schou Nielsen J, Meteran H, Ulrik CS, Porsbjerg C, Backer V.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):184-188.e1. doi: 10.1016/j.anai.2017.05.001. Epub 2017 Jun 7.

PMID:
28599992
48.

The asthma-plus syndrome.

Hull JH, Walsted ES, Backer V.

Expert Rev Respir Med. 2017 Jul;11(7):513-515. doi: 10.1080/17476348.2017.1335602. Epub 2017 Jun 9. No abstract available.

PMID:
28544852
49.

High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: A prospective cohort study.

Bjerregaard A, Laing IA, Backer V, Sverrild A, Khoo SK, Chidlow G, Sikazwe C, Smith DW, Le Souëf P, Porsbjerg C.

Clin Exp Allergy. 2017 Aug;47(8):1007-1013. doi: 10.1111/cea.12935. Epub 2017 May 9.

PMID:
28390083
50.

Novel monoclonal treatments in severe asthma.

Meteran H, Meteran H, Porsbjerg C, Backer V.

J Asthma. 2017 Dec;54(10):991-1011. doi: 10.1080/02770903.2017.1296157. Epub 2017 Mar 13. Review.

PMID:
28287273

Supplemental Content

Loading ...
Support Center